Skip to main content

Table 4 Risk of breast cancer subgroups defined by type and receptor status in relation to total duration of breastfeeding

From: Breastfeeding in relation to risk of different breast cancer characteristics

Tumour subgroup

Breastfeeding total in months

Number of cases

Incidence/100000

RR

RR*

Ductal#

     
 

<4.0

59

199

1.00

1.00

 

≥4.0 - <8.0

74

197

0.99 (0.70 - 1.39)

0.99 (0.70 - 1.41)

 

≥8.0 - <13.0

74

206

1.03 (0.73 - 1.45)

1.04 (0.72 - 1.51)

 

≥13.0

79

224

1.12 (0.80 - 1.58)

1.20 (0.81 - 1.78)

 

Missing

12

199

---

---

 

Total

298

207

p-trend:0.45

p-trend:0.26

Lobular

     
 

<4.0

15

51

1.00

1.00

 

≥4.0 - <8.0

21

56

1.11 (0.57 - 2.15)

0.95 (0.48 - 1.88)

 

≥8.0 - <13.0

23

64

1.27 (0.66 - 2.43)

1.02 (0.51 - 2.04)

 

≥13.0

14

40

0.79 (0.38 - 1.63)

0.65 (0.29 - 1.45)

 

Missing

9

150

---

---

 

Total

82

57

p-trend:0.63

p-trend:0.44

Tubular

     
 

<4.0

4

13

1.00

1.00

 

≥4.0 - <8.0

10

27

1.97 (0.62 - 6.29)

2.09 (0.64 - 6.89)

 

≥8.0 - <13.0

7

20

1.43 (0.42 - 4.89)

1.59 (0.43 - 5.91)

 

≥13.0

6

17

1.26 (0.36 - 4.47)

1.56 (0.37 - 6.70)

 

Missing

2

33

---

---

 

Total

29

20

p-trend:.1.00

p-trend:0.75

ERα neg ≤10%#

     
 

<4.0

9

30

1.00

1.00

 

≥4.0 - <8.0

12

32

1.05 (0.44 - 2.50)

1.16 (0.48 - 2.83)

 

≥8.0 - <13.0

13

36

1.18 (0.50 - 2.75)

1.38 (0.55 - 3.47)

 

≥13.0

15

43

1.40 (0.61 - 3.19)

1.61 (0.60 - 4.35)

 

Missing

1

17

---

---

 

Total

50

35

p-trend:0.38

p-trend:0.30

ERα pos >10%

     
 

<4.0

61

206

1.00

1.00

 

≥4.0 - <8.0

85

227

1.10 (0.79 - 1.53)

1.06 (0.75 - 1.48)

 

≥8.0 - <13.0

88

245

1.19 (0.86 - 1.64)

1.13 (0.79 - 1.60)

 

≥13.0

80

227

1.10 (0.79 - 1.54)

1.09 (0.75 - 1.61)

 

Missing

20

332

---

---

 

Total

334

232

p-trend:0.52

p-trend:0.47

ERβ neg ≤10%#

     
 

<4.0

29

98

1.00

1.00

 

≥4.0 - <8.0

38

101

1.04 (0.64 - 1.68)

1.04 (0.63 - 1.70)

 

≥8.0 - <13.0

44

123

1.26 (0.79 - 2.01)

1.26 (0.76 - 2.09)

 

≥13.0

40

114

1.16 (0.72 - 1.87)

1.20 (0.69 - 2.09)

 

Missing

9

150

---

---

 

Total

160

111

p-trend:0.40

p-trend:0.32

ERβ pos >10%

     
 

<4.0

33

111

1.00

1.00

 

≥4.0 - <8.0

41

109

0.98 (0.62 - 1.54)

0.95 (0.59 - 1.53)

 

≥8.0 - <13.0

40

111

0.98 (0.62 - 1.55)

0.93 (0.57 - 1.53)

 

≥13.0

33

94

0.84 (0.52 - 1.35)

0.80 (0.46 - 1.40)

 

Missing

9

150

---

---

 

Total

156

108

p-trend:0.48

p-trend:0.62

PgR neg ≤10%#

     
 

<4.0

42

142

1.00

1.00

 

≥4.0 - <8.0

49

131

0.92 (0.61 - 1.39)

0.91 (0.59 - 1.38)

 

≥8.0 - <13.0

50

139

0.98 (0.65 - 1.48)

0.96 (0.62 - 1.49)

 

≥13.0

49

139

0.98 (0.65 - 1.48)

1.01 (0.63 - 1.63)

 

Missing

9

150

---

---

 

Total

199

138

p-trend:0.98

p-trend:0.90

PgR pos >10%

     
 

<4.0

28

94

1.00

1.00

 

≥4.0 - <8.0

40

107

1.12 (0.69 - 1.82)

1.13 (0.69 - 1.86)

 

≥8.0 - <13.0

43

120

1.25 (0.78 - 2.02)

1.30 (0.78 - 2.16)

 

≥13.0

38

108

1.14 (0.70 - 1.85)

1.24 (0.70 - 2.17)

 

Missing

10

166

---

---

 

Total

159

110

p-trend:0.55

p-trend:0.29

  1. *Adjusted for age at baseline (continuous), education, socioeconomic status, marital status, age at menarche, age at first birth, parity, oophorectomy, age at menopause, oral contraceptive use, hormone replacement therapy use, bmi, alcohol consumption, smoking and height.
  2. #Reference group in heterogeneity analyses.